EXAS vs KMTS · rev $2.76B vs rev $95.1M
EXACT Sciences Corporation (EXAS) versus Kestra Medical Technologies, Ltd. Common Stock (KMTS) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Kestra Medical Technologies, Ltd. Common Stock (KMTS) is a medical instruments & supplies company listed on US.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported KMTS revenue for 2026-04-30 was $95.1M. Net income was -$131.6M. Revenue was up 59.0% from 2025-04-30 to 2026-04-30. KMTS currently screens at market cap $1.24B.
EXAS currently screens at market cap $20.03B. KMTS currently screens at market cap $1.24B.
Not investment advice. Open the EXAS and KMTS stock pages for the full models.
Not investment advice.